NAPHCON FORTE Drug Patent Profile
✉ Email this page to a colleague
When do Naphcon Forte patents expire, and when can generic versions of Naphcon Forte launch?
Naphcon Forte is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in NAPHCON FORTE is naphazoline hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the naphazoline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NAPHCON FORTE?
- What are the global sales for NAPHCON FORTE?
- What is Average Wholesale Price for NAPHCON FORTE?
Summary for NAPHCON FORTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 91 |
| Patent Applications: | 1,963 |
| DailyMed Link: | NAPHCON FORTE at DailyMed |
US Patents and Regulatory Information for NAPHCON FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | NAPHCON FORTE | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 080229-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
